Therapies in Pre-Clinical Studies

Recombinant Human Hepato Regeneration Factor (rh-HRF) is a Chinese patented protein that is being developed as a potential drug candidate to treat acute liver disease. rh-HRF is a protein produced using biotechnology with biological activity in stimulating the growth of human liver cells.

Recombinant Human Kallikrein 1 (rh-K1) is a Chinese patent-pending enzyme produced using biotechnology that is being developed as a potential drug candidate to treat stroke and peripheral vascular disorders, and to prevent blood clots and thrombosis. rhK1 is the world’s first Recombinant Human Kallikrein. Kallikreins are human enzymes that participate in a wide range of functions in the body.

Recombinant Human Trypsin Inhibitor (rh-UTI) is a Chinese patent-pending enzyme produced using biotechnology that is being developed as a potential drug candidate to treat acute pancreatitis.